論文 - 畠山 真吾
-
Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.
Toshikazu Tanaka, Tohru Yoneyama, Daisuke Noro, Kengo Imanishi, Yuta Kojima, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Shizuka Kurauchi, Ippei Takahashi, Chikara Ohyama
International journal of molecular sciences 18 ( 12 ) 2017年12月
-
Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.
Naoki Fujita, Takuya Koie, Chikara Ohyama, Yoshimi Tanaka, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Yasuhiro Hashimoto
International journal of clinical oncology 22 ( 6 ) 1087 - 1093 2017年12月
-
Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.
Yuka Kubota, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hiromichi Iwamura, Jotaro Mikami, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Chikara Ohyama
Oncotarget 8 ( 60 ) 101500 - 101508 2017年11月
-
Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.
Toshikazu Tanaka, Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Atsushi Imai, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Tohru Yoneyama, Hirotaka Horiguchi, Hirotake Kodama, Takahiro Yoneyama
Japanese journal of clinical oncology 47 ( 11 ) 1078 - 1082 2017年11月
-
Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
Teppei Matsumoto, Shingo Hatakeyama, Teppei Ookubo, Koji Mitsuzuka, Shintaro Narita, Takamitsu Inoue, Shinichi Yamashita, Takuma Narita, Takuya Koie, Sadafumi Kawamura, Tatsuo Tochigi, Norihiko Tsuchiya, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama
Medical oncology (Northwood, London, England) 34 ( 12 ) 190 - 190 2017年10月
-
Opacity of big toenail predicts poor prognosis in patients with end-stage renal disease on hemodialysis.
Osamu Soma, Shingo Hatakeyama, Teppei Matsumoto, Toshikazu Tanaka, Yoshimi Tanaka, Shogo Hosogoe, Hirotake Kodama, Hirotaka Horiguchi, Yuka Kubota, Koichi Kido, Masaki Momota, Go Anan, Ikuyo Narita, Ryuji Kitahara, Hisao Saitoh, Tadashi Suzuki, Chikara Ohyama
Clinical and experimental nephrology 2017年10月
-
Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.
Go Anan, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Toshikazu Tanaka, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama
Oncotarget 8 ( 49 ) 86130 - 86142 2017年10月
-
Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Hirotake Kodama, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Go Anan, Ken Fukushi, Takuma Narita, Toshikazu Tanaka, Yuka Kubota, Hirotaka Horiguchi, Masaki Momota, Koichi Kido, Teppei Matsumoto, Osamu Soma, Itsuto Hamano, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama
Oncotarget 8 ( 47 ) 83183 - 83194 2017年10月
-
The role of LIM and SH3 protein-1 in bladder cancer metastasis.
Misaki Sato, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Tomihisa Funyu, Tadashi Suzuki, Chikara Ohyama, Shigeru Tsuboi
Oncology letters 14 ( 4 ) 4829 - 4834 2017年10月
-
Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.
Itsuto Hamano, Shingo Hatakeyama, Hiromichi Iwamurau, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Ayumu Kusaka, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama
Oncotarget 8 ( 37 ) 61404 - 61414 2017年09月
-
Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.
Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama
Oncotarget 8 ( 39 ) 65492 - 65505 2017年09月
-
Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.
Takuma Narita, Shingo Hatakeyama, Takuya Koie, Shogo Hosogoe, Teppei Matsumoto, Osamu Soma, Hayato Yamamoto, Tohru Yoneyama, Yuki Tobisawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
BMC urology 17 ( 1 ) 72 - 72 2017年08月
-
Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.
Daisuke Noro, Tohru Yoneyama, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Hideo Sasaki, Mitsuru Saito, Hiroshi Harada, Tatsuya Chikaraishi, Hideki Ishida, Kazunari Tanabe, Shigeru Satoh, Chikara Ohyama
International journal of molecular sciences 18 ( 8 ) 2017年08月
-
Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.
Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Yoshimi Tanaka, Kazuhisa Hagiwara, Hideaki Hirai, Satoko Morohashi, Hiroshi Kijima, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
Oncotarget 8 ( 30 ) 49749 - 49756 2017年07月
-
Fertility preservation of patients with testicular cancer.
Itsuto Hamano, Shingo Hatakeyama, Chikara Ohyama
Reproductive medicine and biology 16 ( 3 ) 240 - 251 2017年07月
-
Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomy.
Daisuke Noro, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Toshiaki Kawaguchi, Chikara Ohyama
Medical oncology (Northwood, London, England) 34 ( 6 ) 117 - 117 2017年06月
-
Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama
Medical oncology (Northwood, London, England) 34 ( 5 ) 90 - 90 2017年05月
-
Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
European urology focus 2017年04月
-
Clinical relevance of aortic calcification in urolithiasis patients.
Toshikazu Tanaka, Shingo Hatakeyama, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama
BMC urology 17 ( 1 ) 25 - 25 2017年04月
-
Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.
Takuma Narita, Shingo Hatakeyama, Tohru Yoneyama, Shintaro Narita, Shinichi Yamashita, Koji Mitsuzuka, Toshihiko Sakurai, Sadafumi Kawamura, Tatsuo Tochigi, Ippei Takahashi, Shigeyuki Nakaji, Yuki Tobisawa, Hayato Yamamoto, Takuya Koie, Norihiko Tsuchiya, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama
Cancer medicine 6 ( 4 ) 739 - 748 2017年04月